Seeing Is Believing
Currently out of the existing stock ratings of Farzin Haque, 2 are a BUY (100%).
Analyst Farzin Haque, currently employed at JEFFERIES,
Farzin Haque’s has documented 4 price targets and ratings displayed on 1 stocks.
Most recent stock forecast was given on PYXS, Pyxis Oncology at 18-Mar-2025.
Analyst best performing recommendations are on PYXS (PYXIS ONCOLOGY).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Nov-2023
$7
$4.23 (152.71%)
$7
3 months 22 days ago
(24-Mar-2026)
5/11 (45.45%)
$5.64 (414.71%)
187
Buy Since 08-Aug-2024
$8
$5.23 (188.81%)
$7
3 months 22 days ago
(24-Mar-2026)
0/3 (0%)
$6.64 (488.24%)
Buy Since 10-Nov-2023
$5
6 months 27 days ago
(19-Dec-2025)
0/6 (0%)
$3.27 (189.02%)
Buy Since 08-Nov-2024
$8
$5.23 (188.81%)
$13
7 months 22 days ago
(24-Nov-2025)
0/2 (0%)
$2.85 (55.34%)
Buy Since 07-May-2024
$6
$3.23 (116.61%)
$10
1 years 3 months 28 days ago
(18-Mar-2025)
0/2 (0%)
$4.94 (466.04%)
What Year was the first public recommendation made by Farzin Haque?